Report cover image

Human Immunodeficiency Virus (HIV) Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 118 Pages
SKU # APRC20352808

Description

Summary

According to APO Research, The global Human Immunodeficiency Virus (HIV) market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Human Immunodeficiency Virus (HIV) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Immunodeficiency Virus (HIV) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Human Immunodeficiency Virus (HIV) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Human Immunodeficiency Virus (HIV) include Merck & Co., Inc., Mylan, AbbVie, ViiV Healthcare, Genentech, Inc., Genentech, Inc., Cipla, Inc., Bristol-Myers Squibb Company and Boehringer Ingelheim GmbH and etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunodeficiency Virus (HIV).
The Human Immunodeficiency Virus (HIV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Immunodeficiency Virus (HIV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Human Immunodeficiency Virus (HIV) Segment by Company

Merck & Co., Inc.
Mylan
AbbVie
ViiV Healthcare
Genentech, Inc.
Genentech, Inc.
Cipla, Inc.
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH
Human Immunodeficiency Virus (HIV) Segment by Type

Protease Inhibitors
NNRTIs
Coreceptor Antagonists
NRTIs
Entry and Fusion Inhibitors
Integrase Inhibitors
Human Immunodeficiency Virus (HIV) Segment by Application

Clinics
Hospitals
Labs
Human Immunodeficiency Virus (HIV) Segment by Application

Clinics
Hospitals
Labs
Human Immunodeficiency Virus (HIV) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunodeficiency Virus (HIV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Immunodeficiency Virus (HIV) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunodeficiency Virus (HIV).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Human Immunodeficiency Virus (HIV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

118 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Human Immunodeficiency Virus (HIV) by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Protease Inhibitors
2.2.3 NNRTIs
2.2.4 Coreceptor Antagonists
2.2.5 NRTIs
2.2.6 Entry and Fusion Inhibitors
2.2.7 Integrase Inhibitors
2.3 Human Immunodeficiency Virus (HIV) by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Clinics
2.3.3 Hospitals
2.3.4 Labs
2.4 Assumptions and Limitations
3 Human Immunodeficiency Virus (HIV) Breakdown Data by Type
3.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Type (2020-2025)
3.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2026-2031)
4 Human Immunodeficiency Virus (HIV) Breakdown Data by Application
4.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Application (2020-2025)
4.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Human Immunodeficiency Virus (HIV) Market Perspective (2020-2031)
5.2 Global Human Immunodeficiency Virus (HIV) Growth Trends by Region
5.2.1 Global Human Immunodeficiency Virus (HIV) Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Human Immunodeficiency Virus (HIV) Historic Market Size by Region (2020-2025)
5.2.3 Human Immunodeficiency Virus (HIV) Forecasted Market Size by Region (2026-2031)
5.3 Human Immunodeficiency Virus (HIV) Market Dynamics
5.3.1 Human Immunodeficiency Virus (HIV) Industry Trends
5.3.2 Human Immunodeficiency Virus (HIV) Market Drivers
5.3.3 Human Immunodeficiency Virus (HIV) Market Challenges
5.3.4 Human Immunodeficiency Virus (HIV) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue
6.1.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue (2020-2025)
6.1.2 Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Players (2020-2025)
6.2 Global Human Immunodeficiency Virus (HIV) Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Human Immunodeficiency Virus (HIV) Head Office and Area Served
6.4 Global Human Immunodeficiency Virus (HIV) Players, Product Type & Application
6.5 Global Human Immunodeficiency Virus (HIV) Manufacturers Established Date
6.6 Global Human Immunodeficiency Virus (HIV) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Human Immunodeficiency Virus (HIV) Market Size (2020-2031)
7.2 North America Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2020-2025)
7.4 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Human Immunodeficiency Virus (HIV) Market Size (2020-2031)
8.2 Europe Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2020-2025)
8.4 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size (2020-2031)
9.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Country (2020-2025)
9.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Human Immunodeficiency Virus (HIV) Market Size (2020-2031)
10.2 South America Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Human Immunodeficiency Virus (HIV) Market Size by Country (2020-2025)
10.4 South America Human Immunodeficiency Virus (HIV) Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2020-2031)
11.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2020-2025)
11.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Merck & Co., Inc.
12.1.1 Merck & Co., Inc. Company Information
12.1.2 Merck & Co., Inc. Business Overview
12.1.3 Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.1.4 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
12.1.5 Merck & Co., Inc. Recent Developments
12.2 Mylan
12.2.1 Mylan Company Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.2.4 Mylan Human Immunodeficiency Virus (HIV) Product Portfolio
12.2.5 Mylan Recent Developments
12.3 AbbVie
12.3.1 AbbVie Company Information
12.3.2 AbbVie Business Overview
12.3.3 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.3.4 AbbVie Human Immunodeficiency Virus (HIV) Product Portfolio
12.3.5 AbbVie Recent Developments
12.4 ViiV Healthcare
12.4.1 ViiV Healthcare Company Information
12.4.2 ViiV Healthcare Business Overview
12.4.3 ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.4.4 ViiV Healthcare Human Immunodeficiency Virus (HIV) Product Portfolio
12.4.5 ViiV Healthcare Recent Developments
12.5 Genentech, Inc.
12.5.1 Genentech, Inc. Company Information
12.5.2 Genentech, Inc. Business Overview
12.5.3 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.5.4 Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
12.5.5 Genentech, Inc. Recent Developments
12.6 Genentech, Inc.
12.6.1 Genentech, Inc. Company Information
12.6.2 Genentech, Inc. Business Overview
12.6.3 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.6.4 Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
12.6.5 Genentech, Inc. Recent Developments
12.7 Cipla, Inc.
12.7.1 Cipla, Inc. Company Information
12.7.2 Cipla, Inc. Business Overview
12.7.3 Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.7.4 Cipla, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
12.7.5 Cipla, Inc. Recent Developments
12.8 Bristol-Myers Squibb Company
12.8.1 Bristol-Myers Squibb Company Company Information
12.8.2 Bristol-Myers Squibb Company Business Overview
12.8.3 Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.8.4 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Product Portfolio
12.8.5 Bristol-Myers Squibb Company Recent Developments
12.9 Boehringer Ingelheim GmbH
12.9.1 Boehringer Ingelheim GmbH Company Information
12.9.2 Boehringer Ingelheim GmbH Business Overview
12.9.3 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.9.4 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio
12.9.5 Boehringer Ingelheim GmbH Recent Developments
12.10 Boehringer Ingelheim GmbH
12.10.1 Boehringer Ingelheim GmbH Company Information
12.10.2 Boehringer Ingelheim GmbH Business Overview
12.10.3 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Business (2020-2025)
12.10.4 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio
12.10.5 Boehringer Ingelheim GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.